Chiesi’s Trimbow recommended for use within NHS Scotland

Pharma Times

18 August 2022 - The SMC approval brings much needed boost to asthma sufferers across Scotland.

Chiesi has announced that the SMC has recommended Trimbow – comprised of beclometasone dipropionate, formoterol, glycopyrronium – as an option for use within NHS Scotland.

Read Pharma Times article

Michael Wonder

Posted by:

Michael Wonder